COVID-19

Yuling Han, Xiaohua Duan, Liuliu Yang, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2021;589(7841):270-275. doi:10.1038/s41586-020-2901-9

Abbas Shafiee, Lida Moradi, Mayasari Lim, Jason Brown. Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective. Stem Cells Translational Medicine. 2021;10(1):27-38. doi:10.1002/sctm.20-0197

Louisa Helms, Silvia Marchiano, Ian B. Stanaway, et al. Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations. JCI insight. 2021;6(24):e154882. doi:10.1172/jci.insight.154882

Jeonghwan Youk, Taewoo Kim, Kelly V. Evans, et al. Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2. Cell Stem Cell. 2020;27(6). doi:10.1016/j.stem.2020.10.004

Vanessa Monteil, Hyesoo Kwon, Patricia Prado, et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020;181(4):905-913.e7. doi:10.1016/j.cell.2020.04.004

Laura Pellegrini, Anna Albecka, Donna L. Mallery, et al. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids. Cell Stem Cell. 2020;27(6):951-961.e5. doi:10.1016/j.stem.2020.10.001

Jie Zhou, Cun Li, Xiaojuan Liu, et al. Infection of bat and human intestinal organoids by SARS-CoV-2. Nature Medicine. 2020;26(7):1077-1083. doi:10.1038/s41591-020-0912-6

Arun Sharma, Gustavo Garcia, Yizhou Wang, et al. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection. Cell Reports. Medicine. 2020;1(4):100052. doi:10.1016/j.xcrm.2020.100052